Shares of Regencell Bioscience Holdings Limited (NASDAQ:RGC - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $14.75, but opened at $14.30. Regencell Bioscience shares last traded at $15.15, with a volume of 290,187 shares.
Regencell Bioscience Trading Down 2.8%
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Regencell Bioscience stock. Greenfield Savings Bank bought a new stake in Regencell Bioscience Holdings Limited (NASDAQ:RGC - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,000 shares of the company's stock, valued at approximately $187,000. 0.13% of the stock is owned by institutional investors.
About Regencell Bioscience
(
Get Free Report)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Further Reading
Before you consider Regencell Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.
While Regencell Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
